ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.503,80
-0,52%
S&P 500
5.631,22
0,28%
Dow Jones
40.211,72
0,53%
Euro vs US Dollar
1,08996
0,00%
Bitcoin
63.367,36
-2,29%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Hepion Pharmaceuticals Inc (PK) (CTRVP)

  7. Hepion Pharmaceuticals Inc (PK) (CTRVP) News

CTRVP

Hepion Pharmaceuticals (PK) (CTRVP)

Hepion Pharmaceuticals Inc (PK)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:CTRVP
DatumZeitQuelleÜberschriftSymbolFirma
30/06/202212h01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
28/06/202215h47Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
27/06/202212h06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
24/06/202222h25Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
06/06/202222h17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
31/05/202222h53Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
27/05/202214h45Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
16/05/202222h46Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
29/04/202223h29Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
20/04/202223h30Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
08/04/202223h27Edgar (US Regulatory)Annual Report (10-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
14/02/202212h16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
10/02/202214h38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
19/01/202216h49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
12/01/202216h09Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
10/01/202212h05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
04/01/202212h01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
21/12/202114h25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
30/11/202114h10Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
26/11/202112h09Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
19/11/202123h01Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
16/11/202114h54Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
15/11/202122h50Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
08/10/202122h31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/10/202122h25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
30/09/202123h23Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
29/09/202115h23Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
13/09/202114h29Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/09/202112h00Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
23/08/202115h20Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
 Showing the most relevant articles for your search:USOTC:CTRVP

Kürzlich von Ihnen besucht

LSE
NDIA
Ish India Usd A
NASDAQ
RVSB
Riverview Bancorp
LSE
0RKD
Artifex Mundi
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten